Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.39 USD | +13.01% | -9.74% | +21.93% |
May. 30 | NextCure, Inc. Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024 | CI |
May. 02 | NextCure, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.93% | 38.88M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- NXTC Stock
- News NextCure, Inc.
- Transcript : NextCure, Inc. - Special Call